种植优化促进了由人工酵母产生的金色化物和通用三烯酸产量
Shangkun Qiu1, Mariam Dianat Sabet Gilani1, Conrad Müller1
1iAMB-Institute of Applied Microbiology, ABBt-Aachen Biology and Biotechnology, RWTH Aachen University, Aachen, Germany.
New biotechnology
|August 24, 2024
概括
研究人员优化了酵母发酵过程,从人参中产生了新生和人参. 这种合成生物学方法增强了像K化合物这样有价值的生物活性化合物的可持续生产.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 自然产品的合成自然产品的合成
背景情况:
- 人参是一种具有治疗潜力的传统药物,主要是由于人参化物.
- 普罗托帕纳克萨迪是许多达马兰类型人参酸的关键前体.
- 人参根中的这些化合物的低度限制了提取效率.
研究的目的:
- 为了优化发酵条件,使用工程酵母生产protopanaxadiol和ginsenosides.
- 开发一种可扩展和可持续的方法来合成高价值的人参代谢物.
主要方法:
- 利用实验设计 (DoE) 来优化摇瓶种植中的发酵参数.
- 用转基因酵母作为微生物细胞工厂.
- 应用合成生物学和代谢工程原理.
主要成果:
- 在优化条件下达到1.2g/L的protopanaxadiol标位.
- 化合物K的产量增加了7.3倍,达到0.22g/L.
- 证明了各种三类的发酵条件的适应性.
结论:
- 优化的发酵条件使得高效的微生物可以生产原型沙醇和化合物K.
- 这种合成生物学方法为传统提取提供了一个可扩展和可持续的替代方案.
- 开发的方法为工业生产宝贵的人参衍生生物活性化合物铺平了道路.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Designing Growth Media for Bioreactors
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


